Arcutis Biotherapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
SUVRETTA CAPITAL MANAGEMENT, LLC | 05/15/2025 | 11.42 M | $178.66 M | 0.21% | 9.06% |
JENNISON ASSOCIATES LLC | 05/05/2025 | 11.36 M | $177.68 M | -7.93% | 9.01% |
RUBRIC CAPITAL MANAGEMENT LP | 05/14/2025 | 10.97 M | $171.52 M | 0.00% | 8.70% |
BLACKROCK, INC. | 05/02/2025 | 8.89 M | $139.08 M | -2.80% | 7.06% |
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 05/15/2025 | 8.79 M | $137.40 M | 0.00% | 6.97% |
VANGUARD GROUP INC | 05/09/2025 | 6.82 M | $106.63 M | 5.86% | 5.41% |
POLAR CAPITAL HOLDINGS PLC | 05/15/2025 | 6.71 M | $104.89 M | -9.09% | 5.32% |
STATE STREET CORP | 05/15/2025 | 4.47 M | $69.98 M | -9.63% | 3.55% |
GILDER GAGNON HOWE & CO LLC | 05/15/2025 | 4.10 M | $64.06 M | 4.95% | 3.25% |
MORGAN STANLEY | 05/15/2025 | 3.84 M | $60.03 M | -9.55% | 3.05% |
UBS GROUP AG | 05/13/2025 | 2.92 M | $45.67 M | 4.68% | 2.32% |
FRANKLIN RESOURCES INC | 05/13/2025 | 2.76 M | $43.19 M | -16.55% | 2.19% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 2.55 M | $39.84 M | 3.00% | 2.02% |
PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 05/14/2025 | 2.12 M | $33.16 M | 0.00% | 1.68% |
D. E. SHAW & CO., INC. | 05/15/2025 | 1.99 M | $31.12 M | -20.85% | 1.58% |
ENSIGN PEAK ADVISORS, INC | 05/14/2025 | 1.99 M | $31.10 M | -16.25% | 1.58% |
AMERICAN CENTURY COMPANIES INC | 05/13/2025 | 1.65 M | $25.84 M | 1.30% | 1.31% |
GW&K INVESTMENT MANAGEMENT, LLC | 05/05/2025 | 1.51 M | $23.65 M | -2.06% | 1.20% |
PARADIGM BIOCAPITAL ADVISORS LP | 05/15/2025 | 1.47 M | $22.92 M | 100.00% | 1.16% |
CORMORANT ASSET MANAGEMENT, LP | 05/15/2025 | 1.35 M | $21.11 M | -26.03% | 1.07% |
INVESCO LTD. | 05/12/2025 | 1.33 M | $20.78 M | 17.95% | 1.05% |
GOLDMAN SACHS GROUP INC | 06/27/2025 | 1.10 M | $17.26 M | -15.52% | 0.88% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 05/15/2025 | 1.09 M | $17.09 M | -0.37% | 0.87% |
CANDRIAM S.C.A. | 05/14/2025 | 1.04 M | $16.20 M | -0.63% | 0.82% |
NORTHERN TRUST CORP | 05/13/2025 | 976.07 K | $15.27 M | -1.51% | 0.77% |
CERCANO MANAGEMENT LLC | 05/13/2025 | 928.70 K | $14.52 M | -26.02% | 0.74% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 860.77 K | $13.46 M | -2.05% | 0.68% |
TEJARA CAPITAL LTD | 05/13/2025 | 846.22 K | $13.23 M | -4.58% | 0.67% |
POINT72 ASSET MANAGEMENT, L.P. | 07/21/2025 | 830.48 K | $12.99 M | -52.64% | 0.66% |
05/12/2025 | 815.82 K | $12.76 M | 100.00% | 0.65% | |
FEDERATED HERMES, INC. | 05/08/2025 | 737.56 K | $11.54 M | 49.63% | 0.59% |
SIMPLIFY ASSET MANAGEMENT INC. | 05/13/2025 | 660.56 K | $10.33 M | -11.01% | 0.52% |
PRUDENTIAL FINANCIAL INC | 05/13/2025 | 593.20 K | $9.28 M | 0.11% | 0.47% |
ABRDN PLC | 05/13/2025 | 587.54 K | $9.19 M | 21.88% | 0.47% |
JPMORGAN CHASE & CO | 05/12/2025 | 543.38 K | $8.50 M | -52.40% | 0.43% |
FISHMAN JAY A LTD/MI | 04/22/2025 | 533.15 K | $8.34 M | -0.61% | 0.42% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 514.95 K | $8.05 M | -4.01% | 0.41% |
MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 473.63 K | $7.41 M | -79.50% | 0.38% |
FIRST TRUST ADVISORS LP | 05/14/2025 | 440.19 K | $6.88 M | 67.28% | 0.35% |
STEMPOINT CAPITAL LP | 05/15/2025 | 440.07 K | $6.88 M | -12.16% | 0.35% |
BALYASNY ASSET MANAGEMENT L.P. | 05/15/2025 | 427.43 K | $6.69 M | 314.42% | 0.34% |
WOODLINE PARTNERS LP | 05/15/2025 | 410.00 K | $6.41 M | 100.00% | 0.33% |
DEUTSCHE BANK AG\ | 05/09/2025 | 381.36 K | $5.96 M | -1.59% | 0.30% |
LAZARD ASSET MANAGEMENT LLC | 05/15/2025 | 374.08 K | $5.85 M | -3.66% | 0.30% |
PRIVIUM FUND MANAGEMENT B.V. | 05/09/2025 | 325.71 K | $5.09 M | 0.00% | 0.26% |
PDT PARTNERS, LLC | 05/15/2025 | 317.47 K | $4.97 M | -0.70% | 0.25% |
CITADEL ADVISORS LLC | 05/15/2025 | 310.08 K | $4.85 M | 247.74% | 0.25% |
CITIGROUP INC | 05/12/2025 | 301.55 K | $4.72 M | -7.86% | 0.24% |
BANK OF NEW YORK MELLON CORP | 04/29/2025 | 300.03 K | $4.69 M | -1.63% | 0.24% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 292.10 K | $4.57 M | 20.95% | 0.23% |
Arcutis Biotherapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 184 institutional investors and hedge funds held shares of Arcutis Biotherapeutics, Inc.. The most heavily invested institutionals were:
SUVRETTA CAPITAL MANAGEMENT, LLC: 11.54 M
JENNISON ASSOCIATES LLC: 11.11 M
Frazier Life Sciences Management, L.P.: 9.87 M
BlackRock, Inc.: 8.53 M
Polar Capital Holdings Plc: 5.01 M
GILDER GAGNON HOWE & CO LLC: 4.16 M
99.19% of Arcutis Biotherapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 87.44 M shares in the last 24 months. This purchase volume represents approximately $1.46 B in transactions.